Format

Send to

Choose Destination
Nat Commun. 2017 Aug 21;8(1):298. doi: 10.1038/s41467-017-00129-y.

ROCKII inhibition promotes the maturation of human pancreatic beta-like cells.

Author information

1
Department of Surgery, Weill Cornell Medical College, New York, 10065, USA.
2
Department of Biochemistry, Weill Cornell Medical College, New York, 10065, USA.
3
Genomic Resource Core Facility, Weill Cornell Medical College, New York, 10065, USA.
4
Department of Surgery, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, 19104, USA.
5
Department of Surgery, Weill Cornell Medical College, New York, 10065, USA. shc2034@med.cornell.edu.
6
Department of Biochemistry, Weill Cornell Medical College, New York, 10065, USA. shc2034@med.cornell.edu.

Abstract

Diabetes is linked to loss of pancreatic beta-cells. Pluripotent stem cells offer a valuable source of human beta-cells for basic studies of their biology and translational applications. However, the signalling pathways that regulate beta-cell development and functional maturation are not fully understood. Here we report a high content chemical screen, revealing that H1152, a ROCK inhibitor, promotes the robust generation of insulin-expressing cells from multiple hPSC lines. The insulin expressing cells obtained after H1152 treatment show increased expression of mature beta cell markers and improved glucose stimulated insulin secretion. Moreover, the H1152-treated beta-like cells show enhanced glucose stimulated insulin secretion and increased capacity to maintain glucose homeostasis after transplantation. Conditional gene knockdown reveals that inhibition of ROCKII promotes the generation and maturation of glucose-responding cells. This study provides a strategy to promote human beta-cell maturation and identifies an unexpected role for the ROCKII pathway in the development and maturation of beta-like cells.Our incomplete understanding of how pancreatic beta cells form limits the generation of beta-like cells from human pluripotent stem cells (hPSC). Here, the authors identify a ROCKII inhibitor H1152 as increasing insulin secreting cells from hPSCs and improving beta-cell maturation on transplantation in vivo.

PMID:
28824164
PMCID:
PMC5563509
DOI:
10.1038/s41467-017-00129-y
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center